Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26 ...
Longevity Medical Institute® today announced the launch of its AI-enhanced full-body MRI program, the first of its kind in Los Cabos, Mexico expanding the Institute's advanced diagnostic capabilities ...
Lord Brady discovered he had the disease after taking a PSA blood test that indicates cancer risk. This was followed by two ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
I revved up my longevity protocols and sought out the latest predictive screenings. Was I seizing control of my health or ...
Lancs Live on MSN
Dad ignored red flag habit of 'silent killer' claiming one in eight men before diagnosis
Ed Matthews put his frequent toilet trips down to drinking too much ...
Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth ...
A PSA test in midlife could help to identify men at low risk of prostate cancer, supporting screening strategies and reducing overdiagnosis.
Dermatomyositis is a rare autoimmune disease that typically affects the skin, muscle and respiratory system. Patients with dermatomyositis usually require prompt treatment with intense ...
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results